Beta Drugs Share Price
₹2,072.20 +52.2 (2.58%)
28 Dec, 2024 01:54
Start SIP in BETA
Start SIPPerformance
- Low
- ₹2,041
- High
- ₹2,148
- 52 Week Low
- ₹1,060
- 52 Week High
- ₹2,326
- Open Price₹2,080
- Previous Close₹2,020
- Volume4,700
Investment Returns
- Over 1 Month -5.47%
- Over 3 Month + 24.08%
- Over 6 Month + 71.82%
- Over 1 Year + 38.32%
Smart Investing Starts Here Start SIP with Beta Drugs for Steady Growth!
Beta Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -
- PEG Ratio
- -
- Market Cap Cr
- 1,992
- P/B Ratio
- 12.7
- Average True Range
- 100.15
- EPS
- 37.9
- Dividend Yield
- 0
- MACD Signal
- 16.03
- RSI
- 48.24
- MFI
- 33.42
Beta Drugs Financials
Beta Drugs Technicals
EMA & SMA
Current Price
₹2,072.20
+
52.2
(2.58%)
- Bullish Moving Average 9
- Bearish Moving Average 7
- 20 Day
- ₹2,098.34
- 50 Day
- ₹2,026.37
- 100 Day
- ₹1,862.65
- 200 Day
- ₹1,643.59
Resistance and Support
2087.13
- R3 2,239.87
- R2 2,193.93
- R1 2,133.07
- S1 2,026.27
- S2 1,980.33
- S3 1,919.47
Beta Drugs Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-06 | Quarterly Results | |
2024-10-19 | To consider Fund Raising | |
2024-05-14 | Audited Results | |
2023-11-07 | Quarterly Results & Others | To consider the Migration of the Equity shares of the Company from Emerge-SME Platform of National Stock Exchange of India Limited ( NSE Emerge ) to the Main board of NSE and BSE. |
2023-05-08 | Audited Results |
Beta Drugs F&O
About Beta Drugs
- NSE Symbol
- BETA
- BSE Symbol
- 531481
- Chairperson & Managing Director
- Mr. Rahul Batra
- ISIN
- INE351Y01019
Similar Stocks to Beta Drugs
Beta Drugs FAQs
Beta Drugs share price is ₹2,072 As on 28 December, 2024 | 01:40
The Market Cap of Beta Drugs is ₹1992.2 Cr As on 28 December, 2024 | 01:40
The P/E ratio of Beta Drugs is As on 28 December, 2024 | 01:40
The PB ratio of Beta Drugs is 12.7 As on 28 December, 2024 | 01:40
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.